Advanced Analytics
September 20, 2026Pharmacometrics
September 22, 2026
InCSD supports regulatory development strategies, health authority interactions, and submission planning by integrating clinical, statistical, and CMC expertise. Our approach aligns development activities and supporting evidence with applicable regulatory requirements to inform decisions throughout the product lifecycle.
Regulatory Strategy & Planning
- Global regulatory development strategy and pathway assessment
- Regulatory requirements and intelligence across relevant jurisdictions
- Regulatory development planning and milestone strategy
- Health authority meeting strategy, preparation, and briefing support
- Orphan drug, pediatric, and expedited development program strategy
- Regulatory risk and evidence-gap assessment
Submission Evidence & Documentation
- IND, NDA, BLA, and other applicable regulatory submission planning and support
- CTD/eCTD dossier strategy, organization, and documentation review
- Clinical, statistical, and CMC regulatory document development and integration
- Submission content review, quality control, and readiness assessment
- Regulatory briefing documents and supporting scientific evidence
- Coordination of electronic submission preparation and publishing, as applicable
Review Management & Lifecycle Support
- Health authority correspondence and response strategy
- Information request and deficiency response support
- Regulatory review issue assessment and resolution planning
- Post-approval commitments and regulatory change management support
- Regulatory lifecycle planning and maintenance support
- Ongoing regulatory requirements assessment